AEON BIOPHARMA, INC.
Profile
Company Names
AEON BIOPHARMA, INC.
ALPHAEON CORP
Addresses
5 PARK PLAZA, SUITE 1750, IRVINE, CA 92614
4040 MACARTHUR BOULEVARD, SUITE 260, NEWPORT BEACH, CA 92660
18191 VON KARMAN AVENUE, SUITE 500, IRVINE, CA 92612
Phone Numbers
949-298-2211
(949) 260-1700
949-284-4555
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER HEALTH CARE
Year Incorporated:
2012
State Incorporated:
DELAWARE
Total Amount Raised:
$197,060,133.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-07-29
$30,000,000.00
$30,000,000.00
$0.00
Debt
5
2021-12-08
$24,500,000.00
$25,000,000.00
$500,000.00
Debt
4
2020-08-25
$30,000,000.00
$30,000,000.00
$0.00
Debt
3
2016-07-26
$5,500,000.00
$55,000,000.00
$49,500,000.00
2
2015-11-10
$80,060,118.00
$150,000,000.00
$69,939,882.00
Equity
1
2015-01-14
$27,000,015.00
$40,500,005.00
$13,499,990.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIET
TAMMENOMS
BAKKER
DIRECTOR
SIMONE
BLANK
DIRECTOR
JOST
FISCHER
DIRECTOR
ROBERT
GRANT
DIRECTOR
EAGLE TECHNOLOGIES, INC.
| MYOSCIENCE INC
| NANOSCALE COMPONENTS INC
| RESHAPE MEDICAL, INC.
| NANOSCALE COMPONENTS INC.
| NANOSCALE COMPONENTS, INC.
| FIELDTEK, INC
| START LIGHTING, INC.
| ACTIVESOUL, INC.
| ZELEGENT, INC.
| FLYREEL, INC.
| ALPHAEON 1 LLC
| AEON BIOPHARMA, INC.
| ALPHAEON CREDIT HOLDCO LLC
| ZELEGENT HOLDCO LLC
| ACV WENATCHEE SUTTON PLACE LLC
ROBERT
E.
GRANT
EXECUTIVE OFFICER, DIRECTOR
BOSUN
HAU
DIRECTOR
ROBERT
HAYMAN
DIRECTOR
RICHARD
LINDSTROM
DIRECTOR
VERTICAL HEALTH SOLUTIONS INC
| OCULAR THERAPEUTIX, INC
| FORSIGHT VISION6, INC.
| ENCORE VISION, INC.
| ALPHAEON CORP
| TEARLAB CORP
| POGOTEC, INC.
| IMPRIMIS PHARMACEUTICALS, INC.
| SIGHTLIFE SURGICAL, INC.
| UNITED VISION PARTNERS HOLDINGS, LLC
| EQUINOX, INC.
| IANTECH, INC.
| CORNEAGEN INC.
| EQUINOX OPHTHALMIC, INC.
| THEROPTIX, INC.
| LENTECHS LLC
| SURFACE OPHTHALMICS, INC.
| SYDNEXIS, INC.
| CG HOLDING CO.
| IOR HOLDINGS, INC.
| VINCI PHARMACEUTICALS, INC.
WILLIAM
LINK
EXECUTIVE OFFICER, DIRECTOR
NEOVISTA INC
| LENSX LASERS INC
| DOSE MEDICAL CORP
| SECOND SIGHT MEDICAL PRODUCTS INC
| OCULEVE, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| ALPHAEON CORP
| ONEFOCUS VISION, INC.
| PRELUDE CORP
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| SIGHTLIFE SURGICAL, INC.
| RXSIGHT, INC.
| TEARCLEAR CORP.
| EYEBRAIN MEDICAL, INC.
| CORNEAGEN INC.
| ALLEGRO OPHTHALMICS, LLC
| VIALASE, INC.
| EQUINOX OPHTHALMIC, INC.
| NEUROLENS, INC.
VIKRAM
MALIK
DIRECTOR
DARREN
O-BRIEN
DIRECTOR
ORIGAMI OPPORTUNITIES FUND III OFFSHORE MASTER, L.P.
| ORIGAMI OPPORTUNITIES FUND III, L.P.
| ORIGAMI OPPORTUNITIES FUND III OFFSHORE, L.P.
| TRIDENT EXPLORATION CORP.
| ORIGAMI OPPORTUNITIES FUND IV, L.P.
| ORIGAMI OPPORTUNITIES FUND IV OFFSHORE, L.P.
| ALPHAEON 1 LLC
| AEON BIOPHARMA, INC.
| ALPHAEON CREDIT HOLDCO LLC
| ZELEGENT HOLDCO LLC
ALEX
WILSON
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-07-29
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-12-08
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-08-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-08-25
D
OTHER HEALTH CARE
WHOLESALE-MEDICAL, DENTAL + HOSPITAL EQUIPMENT + SUPPLIES [5047]
DECLINE TO DISCLOSE
2016-07-26
D
OTHER HEALTH CARE
WHOLESALE-MEDICAL, DENTAL + HOSPITAL EQUIPMENT + SUPPLIES [5047]
DECLINE TO DISCLOSE
Equity
2015-11-10

